We are live on ! Find out more
BIA

Biondo Investment Advisors Portfolio holdings

AUM $780M
1-Year Est. Return 21.03%
This Fund
S&P 500
This Quarter Est. Return
+7.54%
1 Year Est. Return
+21.03%
3 Year Est. Return
+89.14%
5 Year Est. Return
+116.93%
10 Year Est. Return
+716.37%
AUM
$296M
AUM Growth
+$15.4M
Cap. Flow
-$1.17M
Cap. Flow %
-0.4%
Top 10 Hldgs %
45.09%
Holding
83
New
7
Increased
33
Reduced
28
Closed
6

Top Buys

Rank Stock Value
1
ABMD
Abiomed Inc
ABMD
+$4.24M
2
VRTX icon
Vertex Pharmaceuticals
VRTX
+$4.12M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$3.68M
4
ILMN icon
Illumina
ILMN
+$2.37M
5
EWZ icon
iShares MSCI Brazil ETF
EWZ
+$1.71M

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$8.85M
2
JPM.WS
JPMorgan Chase
JPM.WS
+$6.66M
3
TUR icon
iShares MSCI Turkey ETF
TUR
+$1.89M
4
LMT icon
Lockheed Martin
LMT
+$825K
5
F icon
Ford
F
+$807K

Sector Composition

Rank Sector Weight
1 Healthcare 29.53%
2 Financials 12.95%
3 Energy 11.42%
4 Communication Services 9.65%
5 Technology 7.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ISRG icon
1
Intuitive Surgical
ISRG
$125B
$23.6M 7.97%
292,464
-1,809
-0.6% -$139K
MA icon
2
Mastercard
MA
$484B
$22.9M 7.76%
225,299
+1,670
+0.7% +$160K
AAPL icon
3
Apple
AAPL
$4.8T
$15.3M 5.17%
540,592
+60,828
+13% +$1.61M
CELG
4
DELISTED
Celgene Corp
CELG
$15M 5.06%
143,042
+1,105
+0.8% +$120K
META icon
5
Meta Platforms (Facebook)
META
$1.64T
$13.5M 4.55%
104,950
-5,400
-5% -$670K
JPM.WS
6
DELISTED
JPMorgan Chase
JPM.WS
$9.25M 3.13%
375,387
-283,940
-43% -$6.66M
IDXX icon
7
Idexx Laboratories
IDXX
$44.5B
$9.09M 3.07%
80,621
-2,070
-3% -$218K
JPM icon
8
JPMorgan Chase
JPM
$901B
$8.72M 2.95%
130,993
+953
+0.7% +$62.1K
ILMN icon
9
Illumina
ILMN
$27.9B
$8.46M 2.86%
47,856
+14,820
+45% +$2.37M
SLB icon
10
SLB Ltd
SLB
$69.4B
$7.61M 2.57%
96,799
+459
+0.5% +$36.4K
BAC.WS.A
11
DELISTED
Bank Of America Corporation Ws A
BAC.WS.A
$7.26M 2.46%
1,570,955
+41,875
+3% +$174K
FANG icon
12
Diamondback Energy
FANG
$55B
$7.03M 2.38%
72,822
+1,492
+2% +$137K
BMY icon
13
Bristol-Myers Squibb
BMY
$123B
$6.79M 2.3%
125,920
+1,113
+0.9% +$71.5K
GOOGL icon
14
Alphabet (Google) Class A
GOOGL
$4.3T
$5.9M 1.99%
146,660
-100
-0.1% -$3.91K
PCRX icon
15
Pacira BioSciences
PCRX
$997M
$5.58M 1.89%
163,073
-1,754
-1% -$68.7K
UAA icon
16
Under Armour
UAA
$3.1B
$5.29M 1.79%
136,695
+5,110
+4% +$206K
CLB icon
17
Core Laboratories
CLB
$516M
$5M 1.69%
44,517
+1,760
+4% +$203K
CVX icon
18
Chevron
CVX
$378B
$4.99M 1.69%
48,492
+389
+0.8% +$39.7K
VFC icon
19
VF Corp
VFC
$6.62B
$4.9M 1.66%
92,833
+1,839
+2% +$106K
REGN icon
20
Regeneron Pharmaceuticals
REGN
$70.5B
$4.61M 1.56%
11,470
+9,185
+402% +$3.68M
ABMD
21
DELISTED
Abiomed Inc
ABMD
$4.55M 1.54%
+35,409
New +$4.24M
F icon
22
Ford
F
$55.7B
$4.23M 1.43%
350,543
-63,933
-15% -$807K
PM icon
23
Philip Morris
PM
$300B
$4.16M 1.41%
42,742
-16
-0% -$1.6K
LMT icon
24
Lockheed Martin
LMT
$117B
$4.13M 1.4%
17,248
-3,298
-16% -$825K
VZ icon
25
Verizon
VZ
$182B
$4.03M 1.36%
77,498
-146
-0.2% -$7.84K
1
2 3 4

Similar funds

LA
Lifeworks Advisors Grand Rapids, Michigan $779M AUM 21.25% 1-Year Est. Return
UBV
United Bank (Virginia) Vienna, Virginia $781M AUM 27.1% 1-Year Est. Return
SG
SCHF (GPE) Wilson, Wyoming $781M AUM 24.06% 1-Year Est. Return
RTM
RH Tailwind Management West Conshohocken, Pennsylvania $781M AUM
TCMX
Technology Crossover Management X Menlo Park, California $781M AUM 18.39% 1-Year Est. Return
QCMNJ
Quantum Capital Management (New Jersey) Northfield, New Jersey $781M AUM 4.96% 1-Year Est. Return
TIS
Titan Investment Solutions London $781M AUM
MO
McMillan Office St. Clair Shores, Michigan $782M AUM

Biondo Investment Advisors's Q3 2016 Portfolio in Review

As of Q3 2016, Biondo Investment Advisors held 83 positions worth $296M, up 5.5% from $280M the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Biondo Investment Advisors's Q3 2016 filing shows 7 new, 33 increased, 28 reduced and 6 closed positions. Its largest new stake was Abiomed Inc: 35,409 shares worth $4.55M. The largest sale was Gilead Sciences, an estimated $8.85M.

By sector, the portfolio is most concentrated in Healthcare at 30% of assets, up from 28% a quarter earlier, followed by Financials and Energy.

  • Biondo Investment Advisors's largest Q3 2016 buy was Abiomed Inc: 35,409 shares worth $4.55M.
  • Biondo Investment Advisors added most to Regeneron Pharmaceuticals in Q3 2016, an estimated $3.68M increase.
  • Biondo Investment Advisors's biggest Q3 2016 reduction was JPMorgan Chase, cutting an estimated $6.66M.
  • Biondo Investment Advisors fully exited Gilead Sciences in Q3 2016, selling an estimated $8.85M.
  • Biondo Investment Advisors's ten largest holdings make up 45% of its $296M portfolio in Q3 2016.
  • Biondo Investment Advisors opened 7 new positions and closed 6 in Q3 2016.
  • Biondo Investment Advisors's portfolio value rose 5.5% quarter-over-quarter to $296M.

Based on Biondo Investment Advisors's 13F filing for Q3 2016, filed 3 Nov 2016.